Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Celestica
CLS
$36.5B
| $3.63M | ﹤0.01% |
250,041
+76,313
| +44% | +$1.02M |
|
|
GWPH
1552
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.63M | ﹤0.01% |
30,000
-3,100
| -9% | -$380K |
|
1553
PUT
Franklin Resources
BEN
$17.2B
| $3.62M | ﹤0.01% |
86,000
+9,400
| +12% | +$390K |
|
1554
PUT
Kinder Morgan
KMI
$68.7B
| $3.62M | ﹤0.01% |
166,700
-213,500
| -56% | -$4.67M |
|
1555
SITE Centers
SITC
$165M
| $3.62M | ﹤0.01% |
224,547
+170,822
| +318% | +$3.15M |
|
1556
Check Point Software Technologies
CHKP
$13.1B
| $3.62M | ﹤0.01% |
35,281
-16,605
| -32% | -$1.63M |
|
1557
Adient
ADNT
$1.5B
| $3.62M | ﹤0.01% |
49,782
+8,874
| +22% | +$583K |
|
1558
3D Systems Corp
DDD
$613M
| $3.62M | ﹤0.01% |
241,869
-50,103
| -17% | -$786K |
|
|
VAL
1559
DELISTED
Valspar
VAL
| $3.61M | ﹤0.01% |
32,508
+21,484
| +195% | +$2.36M |
|
|
ANSS
1560
DELISTED
Ansys
ANSS
| $3.6M | ﹤0.01% |
33,644
+10,660
| +46% | +$1.07M |
|
|
RSX
1561
DELISTED
VanEck Russia ETF
RSX
| $3.59M | ﹤0.01% |
173,853
-6,080
| -3% | -$128K |
|
|
SABA
1562
Saba Capital Income & Opportunities Fund II
SABA
$223M
| $3.59M | ﹤0.01% |
+270,084
| New | +$3.56M |
|
|
GBT
1563
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.59M | ﹤0.01% |
97,380
+70,057
| +256% | +$1.76M |
|
1564
CALL
Fastenal
FAST
$59.5B
| $3.57M | ﹤0.01% |
277,200
+139,200
| +101% | +$1.74M |
|
|
RAI
1565
PUT
DELISTED
Reynolds American Inc
RAI
| $3.56M | ﹤0.01% |
56,500
-692
| -1% | -$41.6K |
|
1566
PUT
NextEra Energy
NEE
$177B
| $3.56M | ﹤0.01% |
110,800
| – | – |
|
1567
New Oriental
EDU
$8.98B
| $3.56M | ﹤0.01% |
58,874
-10,783
| -15% | -$547K |
|
1568
Radian Group
RDN
$4.91B
| $3.54M | ﹤0.01% |
197,058
-4,549
| -2% | -$84.2K |
|
1569
CALL
Martin Marietta Materials
MLM
$33B
| $3.54M | ﹤0.01% |
16,200
+12,000
| +286% | +$2.65M |
|
|
TIVO
1570
DELISTED
Tivo Inc
TIVO
| $3.53M | ﹤0.01% |
188,214
-82,996
| -31% | -$1.59M |
|
|
1571
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $3.53M | ﹤0.01% |
64,600
-272,100
| -81% | -$14.6M |
|
|
LPT
1572
DELISTED
Liberty Property Trust
LPT
| $3.52M | ﹤0.01% |
91,417
+11,526
| +14% | +$450K |
|
1573
Lattice Semiconductor
LSCC
$18.5B
| $3.52M | ﹤0.01% |
508,688
+183,225
| +56% | +$1.3M |
|
1574
CALL
Greif
GEF
$5.04B
| $3.51M | ﹤0.01% |
63,800
+41,800
| +190% | +$2.32M |
|
|
EFII
1575
DELISTED
Electronics for Imaging
EFII
| $3.51M | ﹤0.01% |
71,895
+36,936
| +106% | +$1.7M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.